OpenLB
Open Library of Bioscience
Advanced Search

Journal Information

No journal information available.

Related Publications

Found 1,161 results

Involvement of the hospital pharmacist in securing the chimeric antigen receptor (CAR)-T cell circuit.
Ang��lic Bryla, Sophie Lorent, Audrey Vervacke, Garance Scolas, Laurence Alexandre
Eur J Hosp Pharm. Mar 06, 2025.: Print-Electronic
Source:PubMed
PMID: 40049760 doi:10.1136/ejhpharm-2024-004454
Physicochemical stability of bevacizumab biosimilar CT-P16 (Vegzelma) concentrate for solution stored in original vials after first opening.
Laura Kirsch, Helen Linxweiler, Judith Thiesen, Irene Kraemer
Eur J Hosp Pharm. Mar 06, 2025.: Print-Electronic
Source:PubMed
PMID: 40049761 doi:10.1136/ejhpharm-2024-004436
Physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials in simulated Y-site administration.
Fangyuan Chen, Haiwen Ding, Sheng Liu, Zhaolin Chen, Liqin Tang, Tong Tong
Eur J Hosp Pharm. Mar 06, 2025.: Print-Electronic
Source:PubMed
PMID: 40032507 doi:10.1136/ejhpharm-2024-004358
Stability of dexmedetomidine, ketamine and lidocaine combined injectable solution for analgesia.
Isabelle St-Jean, Djamila Hachemi, Mihaela Friciu, Jean-Marc Forest, Marc Belliveau, David Williamson, Gregoire Leclair
Eur J Hosp Pharm. Mar 05, 2025.: Print-Electronic
Source:PubMed
PMID: 40044403 doi:10.1136/ejhpharm-2024-004177
Classification of non-antineoplastic intravenously administered drugs according to their toxicity risk: the path towards safe drug administration.
Teresa Gim��nez Poder��s, Juan Jos�� Fern��ndez Cabero, Marta Valero Dom��nguez
Eur J Hosp Pharm. Feb 22, 2024.31(2):107-110 Electronic
Source:PubMed
PMID: 35589381 doi:10.1136/ejhpharm-2022-003294
Determination of plasma uracil as a screening for dihydropyrimidine dehydrogenase deficiency: clinical application in oncological treatments.
Eduardo Tejedor-Tejada, Daniel Rubio Calvo, Antonio Garc��a Andreo
Eur J Hosp Pharm. Feb 22, 2024.31(2):124-126 Electronic
Source:PubMed
PMID: 35728953 doi:10.1136/ejhpharm-2021-003210
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years.
Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini, Angelora Di Risio
Eur J Hosp Pharm. Feb 22, 2024.31(2):156-161 Electronic
Source:PubMed
PMID: 35961767 doi:10.1136/ejhpharm-2022-003338
Frequency of measuring body weight in (sub)populations of patients with cancer treated with chemotherapy.
Shirley Kemps, Mostafa Soleyman, Harmen Huls, Mariette Labots, Mirjam Crul
Eur J Hosp Pharm. Feb 22, 2024.31(2):111-116 Electronic
Source:PubMed
PMID: 35606083 doi:10.1136/ejhpharm-2021-003215
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series.
Carlos Guzm��n Cordero, Maria Saez-Torres de Vicente
Eur J Hosp Pharm. Feb 22, 2024.31(2):175-177 Electronic
Source:PubMed
PMID: 36535689 doi:10.1136/ejhpharm-2022-003544
Off-label use of cardiovascular drugs as an indicator of therapeutic need in paediatrics.
Silvia Miriam Cammarata, Giacomo Capone
Eur J Hosp Pharm. Feb 22, 2024.31(2):179 Electronic
Source:PubMed
PMID: 36737229 doi:10.1136/ejhpharm-2022-003635